S&P 500 7,500.58 ▲ 80.48 (+1.08%) DOW 51,564.70 ▲ 72.15 (+0.14%) NASDAQ 26,517.93 ▲ 496.28 (+1.91%) US Markets Closed â€ĸ 02:40 PM ET

FUNI

Hypha Labs, Inc.

Price Chart
Latest Quote

$0.01

+0.00 (+14.17%)
Current Price
Previous Close $0.01
Open $0.01
Day High $0.01
Day Low $0.01
Volume 30,733
Fetched: 2026-06-21T18:40:46
Stock Information
Shares Outstanding 163.90M
Total Debt $1.81M
Cash Equivalents $82K
Net Income $-2.16M
Sector Healthcare
Industry Diagnostics & Research
Market Cap $2.25M
EPS (TTM) $-0.01
Exchange OQB
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$4.31M
Income$-2.16M
Book/sh$-0.02
Cash/sh$0.00
Employees5
Financial Ratios
Quick Ratio0.06
Current Ratio0.07
Returns & Margins
ROA-574.15%
Ownership
Insider Ownership20.33%
Insider & Institutional transactions data not available
Valuation Ratios
P/B-0.72
Analyst Data
Recommendationnone
Technical Indicators
SMA20$0.01
SMA50$0.02
SMA200$0.03
RSI55.67
ATR0.0034
Shares Float130.57M
Volatility1.45
Rel Volume0.55
Performance History
Week-5.52%
Month-15.95%
Quarter-45.20%
6 Months-63.95%
YTD-60.63%
Year-47.71%
3 Years+90.28%
5 Years-76.38%
10 Years-93.15%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-18 $0.01 46,900
2026-06-17 $0.01 167,400
2026-06-16 $0.01 63,100
2026-06-15 $0.01 17,000
2026-06-12 $0.01 153,400
2026-06-11 $0.01 0
2026-06-10 $0.01 103,000
2026-06-09 $0.01 6,300
2026-06-08 $0.01 69,600
2026-06-05 $0.01 220,500
2026-06-04 $0.01 500
2026-06-03 $0.01 78,400
2026-06-02 $0.01 73,400
2026-06-01 $0.01 0
2026-05-29 $0.01 12,000
2026-05-28 $0.01 200,000
2026-05-27 $0.01 14,600
2026-05-26 $0.01 453,400
2026-05-22 $0.01 3,300
2026-05-21 $0.01 34,500
2026-05-20 $0.01 65,100
2026-05-19 $0.02 2,600
About Hypha Labs, Inc.

Hypha Labs, Inc., engages in the research, development, and commercialization of a bioreactor in the United States. It offers Hypha Micropearl bioreactor, a home appliance designed to accelerate the production of beneficial mushrooms for human consumption. Hypha Labs, Inc. was incorporated in 2010 and is headquartered in Las Vegas, Nevada.

📰 Latest News
No news articles available at the moment. Check back later for updates on FUNI.
Period:
Loading...
Income Statement (Annual)
Metric 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Revenue
Reconciled Cost Of Revenue $0 $0 $0 $0
Cost Of Revenue $0 $0 $0 $0
Total Revenue $0 $0 $0 $0
Operating Revenue $0 $0 $0 $0
Expenses
Interest Expense $106,143 $201,769 $364,267 $244,586
Total Expenses $3,001,408 $1,827,027 $437,388 $1,150,465
Other Income Expense $5,650 $672,400 $120,000 $-782,500
Other Non Operating Income Expenses $-20,003 $13,896 $-55,000 $-782,500
Net Non Operating Interest Income Expense $-106,143 $-201,769 $-364,267 $-244,586
Interest Expense Non Operating $106,143 $201,769 $364,267 $244,586
Operating Expense $3,001,408 $1,827,027 $437,388 $1,150,465
General And Administrative Expense $3,001,408 $1,827,027 $437,388 $1,150,465
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-3,101,901 $-1,370,585 $-681,655 $-2,177,551
Net Interest Income $-106,143 $-201,769 $-364,267 $-244,586
Normalized Income $-3,127,554 $-1,890,803 $-856,655 $-2,177,551
Net Income From Continuing And Discontinued Operation $-3,101,901 $-785,429 $246,774 $-2,057,118
Total Operating Income As Reported $-3,001,408 $-1,827,027 $-437,388 $-1,150,465
Net Income Common Stockholders $-3,101,901 $-785,429 $246,774 $-2,249,272
Net Income $-3,101,901 $-785,429 $246,774 $-2,057,118
Net Income Including Noncontrolling Interests $-3,101,901 $-785,429 $246,774 $-2,057,118
Net Income Discontinuous Operations $0 $585,156 $928,429 $120,433
Net Income Continuous Operations $-3,101,901 $-1,370,585 $-681,655 $-2,177,551
Pretax Income $-3,101,901 $-1,356,396 $-681,655 $-2,177,551
Special Income Charges $25,653 $658,504 $175,000 $0
Operating Income $-3,001,408 $-1,827,027 $-437,388 $-1,150,465
Gross Profit $0 $0 $0 $0
Interest Income - - - $0
Interest Income Non Operating - - - $0
Per Share
Diluted EPS - $-0.01 $0.00 $-0.03
Basic EPS - $-0.01 $0.00 $-0.03
Other
Tax Effect Of Unusual Items $0 $138,286 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-2,979,767 $-1,794,516 $-492,388 $-1,932,965
Total Unusual Items $25,653 $658,504 $175,000 $0
Total Unusual Items Excluding Goodwill $25,653 $658,504 $175,000 $0
Reconciled Depreciation $41,644 $18,615 $0 $204,151
EBITDA (Bullshit earnings) $-2,954,114 $-1,136,012 $-317,388 $-1,932,965
EBIT $-2,995,758 $-1,154,627 $-317,388 $-1,932,965
Diluted NI Availto Com Stockholders $-3,101,901 $-785,429 $246,774 $-2,249,272
Tax Provision $0 $14,189 $0 -
Gain On Sale Of Ppe $0 $1,548,998 $0 -
Other Special Charges $32,347 $956,494 - -
Write Off $-58,000 $-66,000 $-175,000 $0
Selling General And Administration $3,001,408 $1,827,027 $437,388 $1,150,465
Other Gand A $3,001,408 $1,827,027 $437,388 $1,150,465
Diluted Average Shares - $101,348,643 $83,925,450 $74,173,304
Basic Average Shares - $101,348,643 $83,925,450 $74,173,304
Impairment Of Capital Assets - - $55,000 -
Preferred Stock Dividends - - - $192,154
Fetched: 2026-02-02
Balance Sheet (Annual)
Metric 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Assets
Net Tangible Assets $-2,103,170 $-926,693 $-1,871,506 $-2,409,272
Total Assets $409,218 $493,805 $1,409,464 $1,339,888
Total Non Current Assets $88,687 $83,615 $643,666 $777,784
Current Assets $320,531 $410,190 $765,798 $562,104
Other Current Assets $26,560 $289,024 $8,570 $12,739
Assets Held For Sale Current $0 $0 $486,222 $393,197
Current Deferred Assets $255,853 $30,000 $0 -
Receivables $0 $0 $0 $100,000
Notes Receivable $0 $0 $0 $100,000
Cash Cash Equivalents And Short Term Investments $38,118 $91,166 $271,006 $56,168
Cash And Cash Equivalents $38,118 $91,166 $271,006 $56,168
Cash Financial $38,118 $91,166 $271,006 $56,168
Other Non Current Assets - - $643,666 $722,784
Prepaid Assets - - - $25,141
Accounts Receivable - - - $335,085
Allowance For Doubtful Accounts Receivable - - - $-139,279
Gross Accounts Receivable - - - $474,364
Debt
Net Debt $1,581,392 $987,069 $2,019,178 $2,292,299
Total Debt $1,646,348 $1,141,501 $2,290,184 $2,348,467
Long Term Debt And Capital Lease Obligation $0 $26,838 $0 $484,998
Current Debt And Capital Lease Obligation $1,646,348 $1,114,663 $2,290,184 $1,863,469
Current Debt $1,619,510 $1,078,235 $2,290,184 $1,863,469
Other Current Borrowings $1,619,510 $1,078,235 $2,290,184 $1,863,469
Long Term Debt - - - $484,998
Liabilities
Total Liabilities Net Minority Interest $2,512,388 $1,420,498 $3,280,970 $3,749,160
Total Non Current Liabilities Net Minority Interest $1 $26,838 $159,156 $795,251
Current Liabilities $2,512,387 $1,393,660 $3,121,814 $2,953,909
Payables And Accrued Expenses $866,039 $278,997 $462,975 $613,166
Payables $472,551 $86,348 $122,094 $200,558
Accounts Payable $472,551 $86,348 $122,094 $200,558
Liabilities Heldfor Sale Non Current - $0 $159,156 $310,253
Other Current Liabilities - - $368,655 $477,274
Equity
Common Stock Equity $-2,438,208 $-1,261,341 $-2,206,154 $-2,743,921
Preferred Stock Equity $335,038 $334,648 $334,648 $334,649
Total Equity Gross Minority Interest $-2,103,170 $-926,693 $-1,871,506 $-2,409,272
Stockholders Equity $-2,103,170 $-926,693 $-1,871,506 $-2,409,272
Retained Earnings $-23,649,327 $-20,547,426 $-19,761,997 $-20,008,771
Preferred Securities Outside Stock Equity $1 $0 $333,600 $333,600
Other Equity Interest - - - $71,745
Other
Ordinary Shares Number $147,121,825 $123,046,825 $87,096,820 $75,146,820
Share Issued $147,121,825 $123,046,825 $87,096,820 $75,146,820
Tangible Book Value $-2,438,208 $-1,261,341 $-2,206,154 $-2,743,921
Invested Capital $-818,698 $-183,106 $84,030 $-395,454
Working Capital $-2,191,856 $-983,470 $-2,356,016 $-2,391,805
Capital Lease Obligations $26,838 $63,266 $0 $330,510
Total Capitalization $-2,103,170 $-926,693 $-1,871,506 $-1,924,274
Additional Paid In Capital $21,063,998 $19,163,039 $17,468,746 $17,117,958
Capital Stock $482,159 $457,694 $421,745 $409,796
Common Stock $147,121 $123,046 $87,097 $75,147
Preferred Stock $335,038 $334,648 $334,648 $334,649
Long Term Capital Lease Obligation $0 $26,838 $0 $229,825
Current Capital Lease Obligation $26,838 $36,428 $0 $100,685
Current Accrued Expenses $393,488 $192,649 $340,881 $412,608
Net PPE $88,687 $83,615 $0 $55,000
Accumulated Depreciation $-11,864 $-1,046 $0 $0
Gross PPE $100,551 $84,661 $0 $55,000
Other Properties $100,551 $84,661 - $55,000
Preferred Shares Number - $1,047,942 $1,047,942 -
Treasury Shares Number - - $0 -
Leases - - - $510,076
Machinery Furniture Equipment - - - $544,344
Properties - - - $0
Fetched: 2026-02-02
Cash Flow Statement (Annual)
Metric 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Free Cash Flow
Free Cash Flow $-412,941 $-1,061,530 $112,525 $-184,786
Operating Activities
Operating Cash Flow $-379,975 $-1,033,875 $112,525 $-184,786
Cash From Discontinued Operating Activities $0 $358,576 $727,394 $277,095
Cash Flow From Continuing Operating Activities $-379,975 $-1,392,451 $-614,869 $-461,881
Operating Gains Losses $32,347 $-592,504 - -
Investing Activities
Capital Expenditure $-32,966 $-27,655 - $-17,722
Investing Cash Flow $-32,966 $2,145,784 $263,333 $-660,371
Cash From Discontinued Investing Activities $0 $0 $-11,667 $-17,722
Cash Flow From Continuing Investing Activities $-32,966 $2,145,784 $275,000 $-642,649
Net Other Investing Changes - - $275,000 $-642,649
Financing Activities
Issuance Of Capital Stock $76,396 $0 $0 $55,600
Financing Cash Flow $359,893 $-1,291,749 $-161,020 $605,393
Cash From Discontinued Financing Activities $0 $-15,784 $-60,920 $-77,972
Cash Flow From Continuing Financing Activities $359,893 $-1,275,965 $-100,100 $683,365
Net Other Financing Charges $-106,743 $-30,000 - -
Net Common Stock Issuance $76,396 $0 - $0
Common Stock Issuance $76,396 $0 - $0
Repurchase Of Capital Stock - $0 $-100 $0
Net Preferred Stock Issuance - $0 $-100 $55,600
Preferred Stock Issuance - - $0 $55,600
Other
Repayment Of Debt $0 $-1,245,965 $-100,000 $-165,000
Issuance Of Debt $390,240 $0 $0 $792,765
Interest Paid Supplemental Data $0 $266,533 $227,691 $113,817
Income Tax Paid Supplemental Data $0 $0 $0 $0
End Cash Position $38,118 $91,166 $271,006 $56,168
Beginning Cash Position $91,166 $271,006 $56,168 $295,932
Changes In Cash $-53,048 $-179,840 $214,838 $-239,764
Net Issuance Payments Of Debt $390,240 $-1,245,965 $-100,000 $627,765
Net Short Term Debt Issuance $197,240 $-1,245,965 $-100,000 $390,000
Short Term Debt Payments $0 $-1,245,965 $-100,000 -
Short Term Debt Issuance $197,240 $0 $0 $390,000
Net Long Term Debt Issuance $193,000 $0 $0 $627,765
Long Term Debt Issuance $193,000 $0 $0 $792,765
Net Business Purchase And Sale $0 $2,173,439 $0 -
Sale Of Business $0 $2,173,439 $0 -
Net PPE Purchase And Sale $-32,966 $-27,655 $0 $-17,722
Purchase Of PPE $-32,966 $-27,655 $0 $-17,722
Change In Working Capital $795,643 $-224,775 $-8,023 $281,771
Change In Other Current Liabilities $-36,428 $-11,309 $0 $-93,242
Change In Other Current Assets $262,464 $-60,454 $4,169 $-813
Change In Payables And Accrued Expense $569,607 $-153,012 $-12,192 $282,584
Change In Accrued Expense $200,838 $-122,691 $66,273 $204,983
Change In Payable $368,769 $-30,321 $-78,465 $77,601
Change In Account Payable $368,769 $-30,321 $-78,465 $77,601
Other Non Cash Items $2,132 $43,050 $135,655 $867,666
Stock Based Compensation $1,850,160 $733,748 $59,154 $566,233
Depreciation Amortization Depletion $41,644 $18,615 $0 $204,151
Depreciation And Amortization $41,644 $18,615 $0 $204,151
Depreciation $41,644 $18,615 $0 -
Gain Loss On Sale Of Business $0 $-1,548,998 $0 -
Net Income From Continuing Operations $-3,101,901 $-1,370,585 $-681,655 $-2,177,551
Preferred Stock Payments - $0 $-100 $0
Asset Impairment Charge - $0 $-120,000 $0
Long Term Debt Payments - - $-100,000 $-165,000
Provisionand Write Offof Assets - - $-175,000 $0
Change In Prepaid Assets - - - $-390
Change In Receivables - - - $-184,612
Changes In Account Receivables - - - $-184,612
Purchase Of Business - - - -
Change In Inventory - - - -
Gain Loss On Investment Securities - - - -
Gain Loss On Sale Of PPE - - - -
Fetched: 2026-02-02